DL
Dishman Carbogen Amcis Limited
Healthcare- Pharmaceuticals
Issuer Summary
Rated A+
By IRR
Investment options
DL
Dishman carbogen amcis ltd.
A rated by IND-RA
11.15%
Yield to maturity
₹1,00,404.77
Min investment
DL
Dishman carbogen amcis limited
A rated by IND-RA
10.80%
Yield to maturity
₹83,082.16
Min investment
View all bonds
Key highlights
Dishman Carbogen Amcis Ltd. is a leading CRAMS (Contract Research and Manufacturing Services) pharma player with global operations focused on oncology and high-potency APIs.
Maintains high compliance standards, ESG policies, and robust internal controls across all global sites.
Experienced promoter group and management with decades of pharma industry experience. Also supported by global advisory boards.
Key Leaders and Motto
SF
Stephan Fritschi
CEO
Vision: To continually innovate and improve, delivering the highest quality, reliable, and timely services through diverse capabilities.
Mission: To be a trusted and reliable partner to international clients, recognized for expert technology transfer and project management.
Contact and other details
Pan
Cin
L74900GJ2007PLC051338
Email
dishman@dishmangroup.com
Address
Dishman Corporate House, Iscon-Bopal Road, Ambli, Ahmedabad-380058
Founded In
2007